PR-CoNCRA Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2016
NCT03120494
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now